the aid library

OPTIONS DE LISTE

Filtre

13383

Télécharger (531)

Voir le PDF (776)

HIV Testing Services Strategy 2017-2020

Zimbabwe, Ministry of Health and Child Care (2017) C1

Télécharger (475)

Voir le PDF (469)

Community based Mental health and Psychosocial support in humanitarian settings: Three-tiered support for children and families (Field test)

UN Children's Fund UNICEF (2018) CC

The CB MHPSS operational guidelines were developed in response to emerging evidence on the determinants of children’s resilience, lessons learned from the evaluation of existing approaches, and the unique challenges that today’s crises pose for children’s safety, wellbeing and optimal developm... more

Télécharger (379)

Voir le PDF (447)

The mhGAP community toolkit: field test version

World Health Organization WHO (2019) CC

The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage. The toolkit provides guidance for programme managers on how to i... more

Ouvrir le lien externe

Antigen-Tests auf SARS-CoV-2 zur professionellen Anwendung

Paul-Ehrlich-Institu PEI (2022) CC

25 März 2022

Télécharger (881)

Voir le PDF (1068)

HIV Testing and Counselling (HTC) Plan, Malawi

Government of Malawi, Ministry of Health (2015) C1

The 5 years plan to scale up HIV Testing and Counselling Services in Malawi 2006-2010

Télécharger (393)

Voir le PDF (323)

WHO recommends countries move away from the use of western blotting and line immunoassays in HIV testing strategies and algorithms. Policy brief

World Health Organization WHO (2019) C_WHO

WHO recommends replacing western blotting and line immunoassays with simpler tests in HIV testing services. These simpler tests include rapid diagnostic tests (RDTs) that can be used at the point-of-care, and enzyme immunoassays (EIAs). These tests get results to the client faster, produce accura... more

Télécharger (532)

Voir le PDF (616)

Diagnostic test for surveillance of lymphatic filariasis: target product profile

World Health Organization WHO (2021) C_WHO

The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t... more

Télécharger (496)

Voir le PDF (1206)

Kenya: Routine HIV Testing and Counseling (D TC) in TB Clinical Settings

Ministry of Health Kenya (2016) CC

Télécharger (494)

Voir le PDF (443)

Laboratory testing for severe acute hepatitis of unknown aetiology in children: interim guidance, 17 June 2022

World Health Organization WHO (2022) C_WHO

This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu... more

Télécharger (1641)

Voir le PDF (2784)

Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations

Bernard M. Branson, S. Michele Owen, Laura G. Wesolowski et Centers for Disease control and Prevention (2014) C_CDC

This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of ... more

Télécharger (222)

Voir le PDF (376)

WHO recommendations HIV testing by lay providers

World Health Organization (WHO) World Health Organization (WHO) (2015) C_WHO

HIV testing Policy Brief July 2015

Télécharger (371)

Voir le PDF (332)

HIV testing in Europe - Evaluation of the impact of the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union

European Centre for Disease Prevention and Control (ECDC) European Centre for Disease Prevention and Control (ECDC) (2016) C2

Technical Report

Télécharger (259)

Voir le PDF (205)

Prediabetes Risk Test

adapted from Bang et al., Ann Intern Med (2009) American Diabetes Association in collaboration with the Centers for Disease Control and Prevention (CDC) (2024) CC2

The "Prediabetes Risk Test" is a tool designed to help individuals assess their risk for prediabetes and type 2 diabetes. The test uses a point-based system with questions about age, gender, family history of diabetes, history of high blood pressure, physical activity level, and weight category. Bas... more

Ouvrir le lien externe

Collection testing and transfusion kit 2021 (CTT kit 2021)

World Health Organization WHO (2021) C_WHO

To provide supply & equipment to collect, test and transfuse 50 blood bags. The new Collection testing and transfusion kit 2021 is specially designed for emergency settings where blood transfusion is crucial. It contains all the necessary supply & equipment needed to collect blood, test it agains... more

Télécharger (924)

Voir le PDF (1404)

Guidelines on HIV self-testing and partner notification - Supplement to consolidated guidelines on HIV testing services

World Health Organization (WHO) World Health Organization (WHO) (2016) C_WHO

Supplement HIV testing services December 2016

Télécharger (647)

Voir le PDF (693)

Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy mass drug administration: target product profile

World Health Organization WHO (2021) C_WHO

TARGET PRODUCT PROFILE

Télécharger (575)

Voir le PDF (840)

Factors Associated with Changes in Uptake of HIV Testing among Young Women (age 15–24) in Tanzania from 2003 to 2012

Phimemon, Rune N., Michael J. Mahande, and Habib O. Ramadhani ICF International (2015) C2

DHS Working Papers No. 119

Télécharger (256)

Voir le PDF (369)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Télécharger (327)

Voir le PDF (272)

WHO recommendations to assure HIV testing quality

World Health Organization (WHO) World Health Organization (WHO) (2015) C_WHO

HIV testing Policy Brief July 2015